Antibody-based protein depletion column

Monday, 06 April, 2009 | Supplied by: Merck


The Seppro IgY depletion platform is an antibody-based technology for processing plasma, serum and plant samples. It enables researchers to detect and analyse commonly obscured biomarkers in samples by removing highly abundant proteins.

The products are built using chicken-derived IgY antibodies, providing selectivity and low cross-reactivity. The Seppro platform removes 14 of the most abundant proteins from human serum or plasma, as well as other high and medium abundant proteins.

Additional products are available for the depletion of mouse and rat samples, as well as the removal of Rubisco.

The platform is complemented by a library of 700 polyclonal IgY antibodies, derived from chicken embryos and prepared using recombinant antigens.

Online: www.sigmaaldrich.com
Phone: 02 9841 0555
Related Products

Beckman Coulter Life Sciences Basophil Activation Test (BAT) for food allergy research

Beckman Coulter Life Sciences introduces its next-generation Basophil Activation Test (BAT) to...

TopoGEN Topoisomerase Assay Kits

TopoGEN provides innovative reagents and kits for topoisomerase research and mechanism-based drug...

Alamar Biosciences NULISAseq Mouse Panel 120 for protein biomarker analysis

The multiplex panel encompasses a wide selection of proteins essential for studying key...


  • All content Copyright © 2025 Westwick-Farrow Pty Ltd